The Peptide Wiki
Mapping Knowledge.
Advancing Discovery.
Last updated
Peptide Profile

Bromocriptine: Research, Dosing, and Where to Buy in 2026

A research-first profile for Bromocriptine, aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.

โš•๏ธ US PRESCRIPTION REQUIRED. Bromocriptine is a prescription medication in the United States. Prescription and controlled-substance rules differ by country, so check your local laws before any purchase or use. Information on this page is educational and not medical advice. Consult a licensed prescribing physician.
Quick Answer

Bromocriptine is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers for Bromocriptine, each linked to its source.

Key Facts
Pharmaceutical
  • 0 aggregated dosing-protocol mentions from source transcripts.
  • 8 PubMed-indexed citations listed in the research table below.
  • 0 vendor recommendations captured from named experts.
Sourced to expert
Check vendor COA
Verify dose w/ clinician

What is Bromocriptine?

Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.

Bromocriptine Dosing Protocols

The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.

No transcript-derived dosing mentions in current source set.

Where to Buy Bromocriptine in 2026

No tracked vendor recommendations for Bromocriptine yet. See our vendor directory.

Side Effects and Safety

Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.

User Reviews

User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.

Research Efficacy Snapshot

Published efficacy percentages cited in PubMed trials and named-expert reports about Bromocriptine. Each line links to the original source.

  • "We computed mean differences (MDs) for continuous outcomes and odds ratios (ORs) for binary endpoints with 95% confidence intervals (CIs)." ยท Adamu U et al, 2025 PubMed
  • "A total of 12 studies [2 randomized controlled trials (RCTs) and 10 observational studies] and 1765 patients (age range 29-33.8 years) were included, of whom 474 (26.9%) received bromocriptine with standard care and 1291 (73.1%) received standard care alone." ยท Adamu U et al, 2025 PubMed
  • "The proportion of patients with improved LV function was higher in those who received bromocriptine with standard care than in those who received standard care alone (OR 0.35; 95% CI: 0.16 to 0.75; P = 0.007)." ยท Adamu U et al, 2025 PubMed
  • "In four studies of 79 patients, low dose bromocriptine (16 mg/day) without levodopa resulted in improvement in 58% of the patients." ยท Lieberman A et al, 1985 PubMed
  • "Only 9% of the patients experienced adverse effects." ยท Lieberman A et al, 1985 PubMed
  • "Most of the patients (63%) and mild or moderate Parkinson disease." ยท Lieberman A et al, 1985 PubMed
  • "In seven studies of 143 patients, high dose bromocriptine (56 mg/day) without levodopa resulted in improvement in 62% of patients, but with 27% having adverse effects." ยท Lieberman A et al, 1985 PubMed
  • "Most of these patients (77%) had mild or moderate disease." ยท Lieberman A et al, 1985 PubMed
  • "In nine studies of 201 patients, low dose bromocriptine (23 mg/day) and levodopa resulted in improvement in 71% of patients with 26% having adverse effects." ยท Lieberman A et al, 1985 PubMed
  • "Most of these patients (66%) had advanced disease, and many had diurnal oscillations in performance." ยท Lieberman A et al, 1985 PubMed

Research and Studies

8 PubMed-indexed papers reference Bromocriptine. Top 8 shown.

Frequently Asked Questions

Is Bromocriptine FDA-approved?

Bromocriptine is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.

How much research has been published on Bromocriptine?

8 PubMed-indexed paper(s) reference Bromocriptine in our current research feed. See the Research and Studies section above for citations.